MARKET NEWS

Provectus Announces Presentation of Initial Results from Phase 1B Trial
Amarantus Announces Issuance of Chinese Patent
Harpoon Therapeutics & AbbVie Announce Licensing & Option Collaboration
Zelluna & Glycostem Announce Development, License & Supply Agreement
Biogen Announces Enrollment Completion of Global Phase 3 Gene Therapy Study
Hovione Technology Completes Pilot-Scale Blister Manufacturing for the Papillon DPI

  FEATURED EDITORIAL

  COMPANY PROFILE

BD is a reliable partner that can provide expertise in highly specific fields to support your drug throughout its lifecycle, from development to launch and beyond. The company is committed to building partnerships with pharmaceutical and biotechnology companies and developing product solutions that meet their needs by leveraging our innovative technologies, extensive global manufacturing, and advanced technical, scientific, medical, and regulatory expertise. Click here for more.

  EXCLUSIVE ONLINE CONTENT

Appili Therapeutics Acquires Clinical-Stage Program From FUJIFILM Toyama Chemical

Appili Therapeutics Acquires Clinical-Stage Program From FUJIFILM Toyama Chemical

Appili Therapeutics Inc. recently announced it has signed an agreement with FUJIFILM Toyama Chemical Co., Ltd. to acquire and develop the novel……

Excision BioTherapeutics Presents Data to Support HIV Cure Using CRISPR Gene Editing Technology

Excision BioTherapeutics Presents Data to Support HIV Cure Using CRISPR Gene Editing Technology

On November 20 at the 6th Annual Personalized Nanomedicine Symposium, researchers working with Excision BioTherapeutics, a gene therapy company focusing on curing viral infectious diseases, delivered two oral presentations to review the multiple years of…

Catalent to Supply BeiGene's BTK Inhibitor BRUKINSAT

Catalent to Supply BeiGene's BTK Inhibitor BRUKINSAT

Catalent recently announced it had entered into a long-term commercial supply agreement with BeiGene, Ltd., a biopharmaceutical company focused on developing….

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

December 4 – Capsules
December 11 – Controlled Release